Abdulhamied Alfaddagh

Abdulhamied Alfaddagh

Interventional cardiologist / Cardiologist
Johns Hopkins Hospital - Kuwait, United States of America

Latest contributions

DCB and latest DES technology for coronary interventions

22 May 2025 – From EuroPCR 2025

Explore the latest in drug-coated balloon (DCB) and drug-eluting stent (DES) technology for coronary interventions. Review predictors of angiographic outcomes, trial data comparing DCB and DES, and insights into treating calcified lesions and bifurcation disease with novel devices.

DCB and latest DES technology for coronary interventions

Caught between a calcified rock and a hard place

19 Dec 2024 – From GulfPCR-GIM 2024

This session delves into the challenges of managing heavily calcified coronary lesions, particularly in complex scenarios like left main bifurcation angioplasty and in elderly patients with unstable angina. Explore innovative techniques to tackle abrupt vessel closure, situations where rotablation may fall short, and state-of-the-art approaches for...

Caught between a calcified rock and a hard place

The five most impactful trials of 2024

19 Dec 2024 – From GulfPCR-GIM 2024

Stay ahead of the curve by exploring the five most impactful cardiovascular intervention trials of 2024. Gain insights into the latest evidence that can transform your clinical practice. Analyze the methodology and applicability of these groundbreaking studies, and learn how to seamlessly integrate them into your...

The five most impactful trials of 2024

Leave nothing behind - Advancing DCB strategies in complex interventions

18 Dec 2024 – From GulfPCR-GIM 2024

Explore cutting-edge strategies for optimizing drug-coated balloon (DCB) procedures in this session. Uncover practical tips to improve outcomes, review key indications, and examine international consensus on DCB use. Case presentations and expert discussions offer insights to refine your approach.

Leave nothing behind

Five most impactful trials in 2023

02 Jan 2024 – From GulfPCR-GIM 2023

Find out how, based on an initial clinical situation, the scientific evidence gathered between January and December on the key subjects selected for 2023, focusing on coronary issues, might have had an impact on daily practice, or is encouraging changes in practice, from MVD in ACS...

Five most impactful trials in 2023